Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cutaneous Phosphorlyated α-synuclein Detection as a Biomarker of Synucleinopathy

NCT04700722 is registered in ClinicalTrials.gov with CND Life Sciences as lead sponsor.

NCT NCT04700722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04700722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cutaneous Phosphorlyated α-synuclein Detection as a Biomarker of Synucleinopathy
Lead sponsor
CND Life Sciences
Phase
Observational
Overall status
Completed
Start date
January 4, 2021
Completion date
November 8, 2023
Enrollment
428 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies, multiple system atrophy, parkinson disease, pure autonomic failure